Clinical trial
Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers
NCT00432770 · Archemix Corp., Industry · Completed
Key facts
| NCT number | NCT00432770 |
|---|---|
| Title | Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers |
| Official title | A Phase 1, Single-Site, Double-Blind,Randomized, Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous Bolus or Intravenous Bolus Followed by Continuous Infusion Administration of ARC1779 Compared to Placebo in Healthy Volunteers |
| Lead sponsor | Archemix Corp., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Thrombosis |
| Intervention type | Drug |
| Interventions | ARC1779 |
| Enrollment | 42 |
| Start date | Dec 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Feb 8, 2007 |
| Last update posted | Apr 20, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: